跳到正文
原文
Medical Xpress·· 2026-10-20AI 评分49

绝经激素疗法不同配方下自身免疫病风险可能有所不同

Autoimmune disease risk may differ by menopausal hormone therapy formulation

AI 导读

一项在 2026 年绝经学会年会上发布的研究结果显示,使用系统雌激素单药治疗的女性,其复合型自身免疫病发生风险高于使用雌激素加孕激素治疗的女性(4.9% vs 4.5%;危险比 1.08,95% CI 1.02–1.14)。

正文
menopause
Credit: RDNE Stock project from Pexels

Progestogen, when used in hormone therapy, is recognized for its benefits in protecting the uterus. A new study suggests that its addition limits the increased risk of composite autoimmune disease associated with estrogen-only therapy. Results of the study were presented at the 2026 Annual Meeting of The Menopause Society in San Diego, Oct. 20–24, 2026.

Previous research has demonstrated an association between menopausal hormone therapy and increased autoimmune disease risk. However, the effect of progestogen on this risk remains unclear.

A new large-scale study sought to compare incident autoimmune disease risk between women receiving systemic estrogen-only and systemic estrogen-plus-progestogen therapy. Outcomes included composite and 20 individual autoimmune diseases occurring 180 days or more after menopausal hormone therapy initiation.

The study used the TriNetX US Collaborative Network and included nearly 110,000 menopausal women who were grouped based on one-to-one propensity score matching.

Results showed that systemic estrogen-only therapy was associated with a modestly increased hazard of composite autoimmune disease compared with estrogen-plus-progestogen therapy (4.9% vs. 4.5%; hazard ratio, 1.08; 95% confidence interval, 1.02–1.14).

Significantly higher hazards were observed in the estrogen-only cohort for systemic lupus erythematosus, rheumatoid arthritis, psoriasis, psoriatic arthritis, multiple sclerosis and lichen sclerosus. No significant differences were observed for other autoimmune diseases.

Although significant associations were observed for selected autoimmune diseases, absolute event rates and risk differences were small. The researchers suggest that prospective studies are needed to further clarify the immunologic effects of different menopausal hormone therapy formulations.

"Our findings suggest that the autoimmune disease risk associated with menopausal hormone therapy may differ by hormone formulation. Although estrogen-only therapy was associated with a modestly higher risk of composite autoimmune disease compared with estrogen-plus-progestogen therapy, the absolute differences were small. These findings should be considered hypothesis-generating and warrant prospective investigation," says lead author Dr. Xuezhi Daniel Jiang, professor of obstetrics and gynecology at Drexel University College of Medicine.

Details of the study will be discussed as part of the presentation "Incident autoimmune disease risk in systemic estrogen versus estrogen-progestogen menopausal hormone therapy."

"Studies like this are important to better inform future prospective studies investigating the association of hormone therapy with risk of autoimmune diseases, which are more common in women than in men," says Dr. Stephanie Faubion, medical director for The Menopause Society.

More information

Incident autoimmune disease risk in systemic estrogen versus estrogen-progestogen menopausal hormone therapy

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Autoimmune disease risk may differ by menopausal hormone therapy formulation (2026, October 20) retrieved 20 October 2026 from https://medicalxpress.com/news/2026-10-autoimmune-disease-differ-menopausal-hormone.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com